ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMM Immupharma Plc

2.125
-0.05 (-2.30%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immupharma Plc LSE:IMM London Ordinary Share GB0033711010 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -2.30% 2.125 2.10 2.15 2.22 2.10 2.22 642,577 16:35:17
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.81M -0.0114 -1.84 7M
Immupharma Plc is listed in the Finance Services sector of the London Stock Exchange with ticker IMM. The last closing price for Immupharma was 2.18p. Over the last year, Immupharma shares have traded in a share price range of 0.83p to 3.78p.

Immupharma currently has 333,403,115 shares in issue. The market capitalisation of Immupharma is £7 million. Immupharma has a price to earnings ratio (PE ratio) of -1.84.

Immupharma Share Discussion Threads

Showing 10826 to 10848 of 39125 messages
Chat Pages: Latest  437  436  435  434  433  432  431  430  429  428  427  426  Older
DateSubjectAuthorDiscuss
24/1/2018
08:15
The placing is peanuts....cos nothings changedExcuse for the city scumbags to have a shake down
kop202
24/1/2018
08:14
Best, would you broadcast the possibility of a possible placing way in advance. N, far better to deny it and then raise funds at a higher price (now) than keep the price depressed in anticipation of a future placing.
homebrewruss
24/1/2018
08:13
Best, Agreed.Tim M. cannot be trusted, he said fully funded to end of 2018, I took him at his word.
che7win
24/1/2018
08:13
This seems like a sensible move. It's possibly enough to fund a second PIII if the first points to efficacy but misses endpoints in some way. If Lupuzor is a bust the company can also try to advance its cancer drug.

It's hard to make much sense of institutional investors who refused to back this technology at 25p, forcing IMM to go with Lanstead, but are now happy to pay 144p with no new data.

mirako
24/1/2018
08:13
Sneaky 146p buy today :)
hamhamham1
24/1/2018
08:12
One of the most bungled placings ever!
czar
24/1/2018
08:11
FWIW think it's good news, could finish in the blue, II's possibly after more ?
jimmmy
24/1/2018
08:11
One thing for sure T MCArthy can not be trusted that's for sure he stated before the previous fund raise that they were fully funded up to phase 3 the we had the placing reason given to further the p140platform and strengthen negotiation footing .We then have today's placing and explanation and posters on this board saying great move you couldn't make it up leaves a very bad taste in the mouth.
best1467
24/1/2018
08:11
Never hit 135
markymark33
24/1/2018
08:07
Bought a few at £1.46.
waterloo01
24/1/2018
08:05
Looks like the head and shoulders will be formed. But didn't expect for this reason. Need a good think now.
makingmillions
24/1/2018
08:01
IMM fully cashed up for negotiations and expansion of P140 high value platform.
stealth wealth
24/1/2018
07:59
Let the Market speak!
ewads
24/1/2018
07:55
Well NY Boy... I did try and warn you (told you so). Now if the tables were turned and you were right you would be accusing me of deramping & doing it for my own agenda (makes you sound like some paranoid conspiracy believer). Quite ironic the morning after you were accusing people of derampig this happens. Makes you seem very very silly.
btfd497
24/1/2018
07:54
Well NY Boy... I did try and warn you (told you so). Now if the tables were turned and you were right you would be accusing me of deramping & doing it for my own agenda (makes you sound like some paranoid conspiracy believer). Quite ironic the morning after you were accusing people of derampig this happens. Makes you seem very very silly.
btfd497
24/1/2018
07:54
what about those guys who informed us on here, who said they had spoken to the company and were given absolute reassurances that no placing would happen?
brad44
24/1/2018
07:54
any broker reviews yet?
qs99
24/1/2018
07:54
50/50 call now lads - I don't like those odds
2prsimo
24/1/2018
07:53
post of the day


NY Boy
23 Jan '18 - 15:53 - 10740 of 10809
0 3 2
Much a do about nothing today, bears have given up with their idiotic placing story, most can see they have been exposed, a few fell for it and those that sold, someone else bought their stock at a cheap price.

Waiting for the next imaginary story to emerge no doubt.

arab3
24/1/2018
07:52
It's not a level playing field folks.We have good news, the share price was rising, and institutions see a good investment.They demand some action and are given it 40p below what we were paying last week.Was Tim doing all these interviews to pump it up?I'm disgusted by this.
che7win
24/1/2018
07:50
Explains the 'flash crash' to £1.50.

Its a prudent move and I doubt is any indicator of the results. It means they are in a stronger position in negotiations (ongoing)and if they need to run a 2nd trial, is partly funded.

Not wildly happy it was leaked into the market (hat's off to those that knew).

waterloo01
24/1/2018
07:49
Very positive imo.

New and existing investors piling in ahead of transformational news.

"The Placing further strengthens the balance sheet and enhances ImmuPharma's position in ongoing and future negotiations with potential partners for Lupuzor(TM)."

someuwin
24/1/2018
07:47
marwalker, they always, always, want to sit in the penny seats for a great show.
divmad
Chat Pages: Latest  437  436  435  434  433  432  431  430  429  428  427  426  Older

Your Recent History

Delayed Upgrade Clock